Avian Influenza Vaccine is a specially designed vaccine aimed at protecting against a specific type of bird flu, known as the H5N1 2.3.4.4b clade. This vaccine works by stimulating the body’s immune system to recognize and fight off the virus if exposed in the future. The study is focused on understanding how well this vaccine can trigger both antibody responses and cell-based immune responses, which are crucial for effective protection against the virus.

Avian Influenza – Avian influenza, also known as bird flu, is an infectious disease caused by influenza viruses that primarily affect birds but can also infect humans. The disease is characterized by symptoms such as fever, cough, sore throat, and muscle aches. In birds, it can cause a range of symptoms from mild illness to severe disease and death. In humans, the disease can progress rapidly, leading to respiratory distress and other complications. The virus spreads through direct contact with infected birds or contaminated environments. Human-to-human transmission is rare but can occur in certain conditions.

Seasonal Influenza – Seasonal influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses that circulate worldwide. It typically presents with symptoms such as fever, cough, sore throat, body aches, and fatigue. The disease progresses over a few days, with symptoms usually resolving within a week, although some individuals may experience lingering fatigue. Influenza viruses are spread through respiratory droplets when an infected person coughs or sneezes. The virus can also be transmitted by touching surfaces contaminated with the virus and then touching the face. Seasonal influenza can lead to complications, especially in young children, the elderly, and individuals with weakened immune systems.